---
title: "Eli Lilly will acquire ADVERUM Biotechnologies, and the company's stock price soared 16% in pre-mark"
description: "Eli Lilly will acquire ADVERUM Biotechnologies, and the company's stock price soared 16% in pre-market trading"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/262636355.md"
published_at: "2025-10-24T12:52:46.000Z"
---

# Eli Lilly will acquire ADVERUM Biotechnologies, and the company's stock price soared 16% in pre-mark

> Eli Lilly will acquire ADVERUM Biotechnologies, and the company's stock price soared 16% in pre-market trading

Eli Lilly will acquire ADVERUM Biotechnologies, and the company's stock price soared 16% in pre-market trading

### Related Stocks

- [LLY.US - Eli Lilly](https://longbridge.com/en/quote/LLY.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Eli Lilly and Company $LLY Shares Acquired by Assetmark Inc. | Assetmark Inc. increased its holdings in Eli Lilly and Company (NYSE: LLY) by 6.0% in Q3, owning 55,360 shares valued at | [Link](https://longbridge.com/en/news/275971336.md) |
| Eli Lilly just delivered fantastic news to investors | Eli Lilly shares have climbed in the double digits this year. | [Link](https://longbridge.com/en/news/269703566.md) |
| BUZZ-Abivax jumps on media reports of Eli Lilly takeover bid | BUZZ-Abivax jumps on media reports of Eli Lilly takeover bid | [Link](https://longbridge.com/en/news/270467110.md) |
| Dynamic Advisor Solutions LLC Purchases 4,692 Shares of Eli Lilly and Company $LLY | Dynamic Advisor Solutions LLC increased its stake in Eli Lilly by 54.8% in Q3, owning 13,261 shares worth $10.1 million. | [Link](https://longbridge.com/en/news/270377016.md) |
| Watts Gwilliam & Co. LLC Reduces Position in Eli Lilly and Company $LLY | Watts Gwilliam & Co. LLC reduced its holdings in Eli Lilly and Company by 70.8% in Q2, now owning 1,083 shares worth $82 | [Link](https://longbridge.com/en/news/269876200.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.